Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Got to dig through the intros and outros but there are usually nuggets there somewhere.

"Carter at ISAR says no one expects repurposing screens to identify more than a few useful drugs for any particular indication. Even so, she says, “repurposed efforts always need to be deployed when you have the emergence of a new disease, because if there is something that’s readily addressable to the population, you absolutely want to identify it rapidly and take it forward.”

AND

"Although ifenprodil has received considerable interest in its potential neuromodulatory activities in psychiatric conditions, including dependency4 and depression,5 it has also been shown to have an immunomodulatory effect.5,6 In an unbiased screen for compounds capable of reducing cell death induced by infection with the influenza strain H5N1, ifenprodil was found to have a protective effect against H5N1-induced lung damage, in part through its ability to alleviate the H5N1-induced cytokine storm and reduce pulmonary infiltration of neutrophils, natural killer cells, and T cells.6 Ifenprodil is being investigated for its potential utility in treating COVID-19 in an ongoing phase 2b/3 clinical trial (NCT04382924).7"

Yep, that's what the plans from CM and MW are about, IMO.
Stroke research now joins COVID/SARS/ARDS, IPF, IBD and CKD...GLTA...